Immunogenetics

, Volume 40, Issue 2, pp 129–134

Cloning and sequence analysis of candidate human natural killer-enhancing factor genes

  • Hungyi Shau
  • Lisa H. Butterfield
  • Robert Chiu
  • Anthony Kim
Original Paper

DOI: 10.1007/BF00188176

Cite this article as:
Shau, H., Butterfield, L.H., Chiu, R. et al. Immunogenetics (1994) 40: 129. doi:10.1007/BF00188176

Abstract

A cytosol factor from human red blood cells enhances natural killer (NK) activity. This factor, termed NK-enhancing factor (NKEF), is a protein of 44000 Mrconsisting of two subunits of equal size linked by disulfide bonds. NKEF is expressed in the NK-sensitive erythroleukemic cell line K562. Using an antibody specific for NKEF as a probe for immunoblot screening, we isolated several clones from a λgt11 cDNA library of K562. Additional subcloning and sequencing revealed that the candidate NKEF cDNAs fell into one of two categories of closely related but non-identical genes, referred to as NKEF A and B. They are 88% identical in amino acid sequence and 71% identical in nucleotide sequence. Southern blot analysis suggests that there are two to three NKEF family members in the genome. Analysis of predicted amino acid sequences indicates that both NKEF A and B are cytosol proteins with several phosphorylation sites each, but that they have no glycosylation sites. They are significantly homologous to several other proteins from a wide variety of organisms ranging from prokaryotes to mammals, especially with regard to several well-conserved motifs within the amino acid sequences. The biological functions of these proteins in other species are mostly unknown, but some of them were reported to be induced by oxidative stress. Therefore, as well as for immunoregulation of NK activity. NKEF may be important for cells in coping with oxidative insults.

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Hungyi Shau
    • 1
  • Lisa H. Butterfield
    • 1
  • Robert Chiu
    • 1
  • Anthony Kim
    • 1
  1. 1.Division of Surgical Oncology, and Jonsson Comprehensive Cancer CenterUCLA School of MedicineLos AngelesUSA